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ABSTRACT
Aneuploidy is a common feature of human solid tumors and is often associated with poor prognosis. There
is growing evidence that oncogenic signaling pathways, which are universally dysregulated in cancer,
contribute to the promotion of aneuploidy. However, the mechanisms connecting signaling pathways to
the execution of mitosis and cytokinesis are not well understood. Here, we show that hyperactivation of
the ERK1/2 MAP kinase pathway in epithelial cells impairs cytokinesis, leading to polyploidization and
aneuploidy. Mechanistically, deregulated ERK1/2 signaling specifically downregulates expression of the F-
box protein Fbxw7b, a substrate-binding subunit of the SCFFbxw7 ubiquitin ligase, resulting in the
accumulation of the mitotic kinase Aurora A. Reduction of Aurora A levels by RNA interference or
pharmacological inhibition of MEK1/2 reverts the defect in cytokinesis and decreases the frequency of
abnormal cell divisions induced by oncogenic H-RasV12. Reciprocally, overexpression of Aurora A or
silencing of Fbxw7b phenocopies the effect of H-RasV12 on cell division. In vivo, conditional activation of
MEK2 in the mouse intestine lowers Fbxw7b expression, resulting in the accumulation of cells with
enlarged nuclei. We propose that the ERK1/2/ Fbxw7b/Aurora A axis identified in this study contributes to
genomic instability and tumor progression.
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Introduction
Aneuploidy is a very common feature of cancer, being present
in 90% of human solid tumors and consistently associated with
a worse prognosis.1,2 Despite its largely detrimental effect on
cellular fitness, aneuploidy is strongly associated with cancer,
possibly because of its ability to generate the phenotypic diver-
sity necessary to adapt to the stringent selection conditions
observed during in vivo tumor development.1,3,4 Aneuploidy
also promotes additional genomic instability by itself leading to
both numerical and structural chromosomal alterations.5-7
One proposed route to aneuploidy is through generation of
an unstable tetraploid intermediate state.8,9 These tetraploid cells
arise mainly from 3 mechanisms: cell fusion, endoreduplication,
and cytokinesis failure or premature exit from mitosis. Consis-
tent with an initiator role of tetraploidy in aneuploidy and
tumorigenesis, cells with high chromosome numbers are fre-
quently observed in early-stage cancers and many tumor cells
exhibit a bimodal distribution of chromosome numbers with a
near-tetraploid peak.8 Experimentally, tetraploid fibroblast or
epithelial cells generate tumors in mice that grow much faster
than their diploid counterparts.10-12 Tetraploidization may help
tolerate the genetic imbalance resulting from chromosomal
instability (CIN) and aneuploidy to promote transformation.3
The mechanisms that cause tetraploidy and aneuploidy are
not clear but accumulating evidence points to a role of onco-
genic signaling pathways.13 Specifically, hyperactive Ras signal-
ing has been implicated in the induction of CIN but the precise
molecular mechanisms involved remain unknown.13,14 We
have recently reported that oncogenic Ras or sustained nuclear
MEK/ERK1/2 signaling induces tetraploidization of epithelial
cells.10 Here, we investigated the molecular basis of this onco-
genic response. We now show that hyperactivation of ERK1/2
MAP kinases (MAPKs) specifically downregulates the F-box
protein isoform Fbxw7b, resulting in the accumulation of
Aurora A, cytokinesis failure and polyploidization. Transgenic
expression of activated MEK2 in mouse intestinal epithelial
cells similarly decreases Fbxw7b levels, concomitantly to the
accumulation of cells with enlarged nuclei, indicative of
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polyploidy. Our results link the activation of a common onco-
genic signaling pathway to the promotion of aneuploidy.
Results
Activated MEK1DD and H-RasV12 induce cytokinesis defects
leading to polyploidization
To study the mechanisms underlying activated Ras or MEK-
induced tetraploidization, we analyzed the cell cycle kinetics of
asynchronously proliferating intestinal epithelial IEC-6 cells
expressing H-RasV12 or MEK1DD (Fig. 1A). FACS analysis of
phospho-histone H3 staining revealed an increased proportion
of IEC-6-H-RasV12 and IEC-6-MEK1DD cells in late G2/M
phase (Fig. 1B), consistent with impairment in mitotic progres-
sion or cytokinesis. To carefully analyze progression through
mitosis, IEC-6 cell populations were transduced with GFP-his-
tone H2B and imaged by time-lapse digital microscopy. Mitotic
events were timed to score defects in chromosome movements,
anaphase progression and cytokinesis. The duration of mitosis
(nuclear envelope breakdown (NEBD) to complete ingression
of the cytokinetic furrow) was unaffected by the expression of
H-RasV12 or MEK1DD (Fig. 1C and 1D). Yet, a significant frac-
tion of IEC-6-H-RasV12 and IEC-6-MEK1DD cells were binu-
cleated (26.1% and 26.3% vs none detected in control cells),
indicative of a failure in cytokinesis (Fig. S1). Cytokinetic fur-
row initiation and ingression occurred with normal kinetics,
but we observed several regression/ingression cycles in H-
RasV12 and MEK1DD-expressing cells (Fig. S1A and S1B), sug-
gesting that binucleation arises from a defect in abscission.15 In
support of this idea, these cells often exhibited long cytoplasmic
bridges and cytokinesis lasted more than 8 times longer than in
control cells (Fig. 1C, 1D, S1A and S1B).
Aurora A is a critical mediator of H-RasV12-induced
cytokinesis failure
The mitotic kinase Aurora A is frequently overexpressed in
human cancer, and its overexpression leads to cytokinesis fail-
ure, tetraploidization and genetic instability in cultured cells
and mouse models.16,17 We thus sought to evaluate the role of
Aurora A in H-RasV12-induced cytokinesis failure. Expression
of H-RasV12 or MEK1DD in IEC-6 cells resulted in a marked
up-regulation of Aurora A (Fig. 2A). Similarly to oncogenic
Ras, overexpression of Aurora A was sufficient to cause cytoki-
nesis failure and impair cell cycle progression of IEC-6 cells
(Fig. 2B-F). Higher upregulation of Aurora A levels also
resulted in multipolar spindles (Fig. 2F).
To directly test the contribution of Aurora A to H-RasV12-
induced cytokinesis failure, we down-regulated the expression
Figure 1. Activated H-RasV12 or MEK1DD induce cytokinesis defects. IEC-6 cells were infected with empty vector, MEK1DD or H-RasV12 and analyzed 2 weeks post-infec-
tion. (A) Immunoblot analysis of proliferating IEC-6 cell populations (nD4). (B) Flow cytometry analysis of phospho-histone H3 (p-H3) expression. Results are expressed as
mean § SEM (n D 3). (C) Timing of mitotic progression revealed by time-lapse video imaging. Mean § SEM of 44 vector, 80 MEK1DD and 92 H-RasV12-expressing IEC-6
cells 2 weeks post-infection. (D) Time-lapse video imaging of representative mitotic progression of IEC-6 cell populations expressing GFP-tagged histone H2B. Scale bar,
5 mm. Arrow, intercellular bridge. , P < 0.005.
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Figure 2. Overexpression of Aurora A impairs cytokinesis and cell division. (A) Immunoblot analysis of Aurora A in proliferating IEC-6 cells infected with vector, MEK1DD or
H-RasV12 (nD 3). (B to F) IEC-6 cells were infected with empty vector or Aurora A-encoding retrovirus and cell populations expressing moderate or high levels of Aurora A
were selected for functional analysis. (B) Immunoblot analysis of Aurora A expression (n D 4). (C) Flow cytometry analysis of p-H3 expression. Results are expressed as
mean§ SEM (nD 3). (D) Time-lapse video imaging of mitotic progression of IEC-6-H-RasV12 cells transduced with GFP-histone H2B and moderately overexpressing Aurora
A. Scale bar, 5 mm. Arrow, intercellular bridge. (E) Timing of mitotic progression of control (Vector) IEC-6 cells (nD 44) or IEC-6 cells expressing moderate (nD 80) or high
(nD 116) levels of Aurora A at 2 weeks post-infection. (F) Quantification of cell division defects. (G to I) IEC-6-H-RasV12 cells were infected or not with lentiviruses encoding
non-target shRNA (shNT) or the indicated Aurora A shRNAs (shAurA). (G) Immunoblot analysis of Aurora A expression (nD 3). (H) Time-lapse video imaging of mitotic pro-
gression of IEC-6-H-RasV12 cells transduced with GFP-histone H2B and infected with Aurora A shRNA. (I) Quantification of cell division defects. , P < 0.005.
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of Aurora A to close-to-normal levels using lentivirus-trans-
duced Aurka shRNAs (Fig. 2G). Complete depletion of Aurora
A impairs mitotic entry and leads to multiple mitosis defects 18
(unpublished observations). Reduction of Aurora A levels with
2 independent shRNAs reverted the defect in cytokinesis tim-
ing induced by H-RasV12, and markedly decreased the fre-
quency of binucleated cells and cells exhibiting long
cytoplasmic bridge, furrow regression and tripolar division
(Fig. 2H and 2I). Overall, these results suggest that Aurora A is
a key effector of oncogenic H-RasV12-mediated tetraploidiza-
tion and aneuploidy.
Oncogenic H-RasV12 induces polyploidization through
ERK1/2 MAPK signaling
Expression of activated MEK1DD up-regulates Aurora A levels
(Fig. 2A) and induces cytokinesis failure (Fig. 1B-D). To assess
the specific contribution of the ERK1/2 MAPK signaling
branch to H-RasV12-induced polyploidy, IEC-6-H-RasV12 cells
were treated with a low dose of the selective MEK1/2 inhibitor,
PD184352. High doses of this compound induce G1 arrest.
Treatment with 1 mM PD184352, which restrains ERK1/2
hyperactivation, decreased the levels of Aurora A to levels seen
in non-transformed cells (Fig. 3A). Importantly, PD184352
markedly reduced the length of cytokinesis and the frequency
of abnormal cell divisions (furrow regression, binucleation,
multipolar spindles) of H-RasV12-expressing cells (Fig. 3B and
3C). Consistent with these observations, long term treatment of
IEC-6-H-RasV12 cells with PD184352 significantly decreased
the proportion of G2/M and polyploid/aneuploid cells
(Fig. 3D-F). Thus, oncogenic H-RasV12 induces cytokinesis
defects, polyploidization and aneuploidy largely through
ERK1/2 signaling.
Hyperactivation of the ERK1/2 pathway downregulates
Fbxw7b expression
We next investigated the molecular mechanism by which
deregulated ERK1/2 signaling up-regulates Aurora A expres-
sion. The abundance of Aurora A is controlled at the level of
transcription and protein turnover.17,19 Specifically, Aurora A
is targeted for degradation at mitotic exit by the anaphase-pro-
moting complex/cyclosome (APC/C) and co-activator Cdh1.20-
22 Expression of H-RasV12 in Cdh1GT/GT MEFs further up-regu-
lated the levels of Aurora A (Fig. S2A) and significantly
increased the frequency of polyploid/aneuploid cells as com-
pared to empty vector (Fig. S2B and S2C). These results argue
that mechanisms other than Cdh1 inactivation contribute to
Aurora A accumulation.
The SCFFbxw7 ubiquitin ligase also promotes Aurora A ubiq-
uitination and degradation.23-25 We thus examined the effect of
H-RasV12 or MEK1DD on the expression of Fbxw7 isoforms in
IEC-6 cells. No change in expression of Fbxw7a was observed,
but the levels of Fbxw7b mRNA and protein were markedly
downregulated in cells with activated Ras or MEK1 (Fig. 4A
and 4B). Actinomycin D-chase experiments revealed no effect
on Fbxw7b mRNA stability, suggesting that regulation takes
place predominantly at the transcriptional level (Fig. 4C).
Treatment of IEC-6-H-RasV12 cells with PD184352 rescued the
expression of Fbxw7b, concomitant to the reduction of Aurora
A levels (Fig. 4D and 4E). These findings were generalized to
human MCF10A mammary epithelial cells expressing H-
RasV12 (Fig. S3).
To address the physiopathological relevance of these cel-
lular studies, we generated a bitransgenic mouse model con-
ditionally expressing activated MEK2DD in the intestine
under control of a doxycline-inducible system (Fig. S4).
Induction of MEK2DD and ensuing hyperactivation of
ERK1/2 signaling resulted in decreased expression of
Fbxw7b in vivo (Fig. 5A), concomitant to an increase in the
frequency of Ki-67-positive cells (Fig. 5B) and phospho-his-
tone H3-positive cells (Fig. 5C) in colonic crypts. Notably,
the average nucleus size was enlarged (with many nuclei
exhibiting atypical morphology) in colon sections of Villin-
rtTA;MEK2DD mice, a finding consistent with the presence
of polyploid/aneuploid cells (Fig. 5D).
Fbxw7b isoform regulates Aurora A levels and the
accuracy of cell division
To specifically assess the impact of Fbxw7 on Aurora A expres-
sion and aneuploidy, the expression of Fbxw7 isoforms was
silenced by RNAi in IEC-6 cells. Depletion of Fbxw7b using
2 distinct siRNAs caused the upregulation of Aurora A expres-
sion, associated with an increase in phospho-histone H3 levels
(Fig. 6A). Silencing of Fbxw7a isoform had no detectable effect.
Cycloheximide-chase experiments revealed that depletion of
Fbxw7b increases the half-life of Aurora A from 1h43 §
10 min to 6 h 45 § 18 min in IEC-6 cells, consistent with a
direct effect on protein turnover (Fig. 6B). Functionally, knock-
down of Fbxw7b expression increased the fraction of IEC-6
cells in G2/M phase (Fig. 6C and S5) and led to the accumula-
tion of cells with >4N DNA content (Fig. 6D).
Fbxw7a depletion also resulted in the accumulation of cells
with >4N DNA, without inducing the accumulation of phos-
pho-histone H3-positive cells (Fig. 6C and 6D). Fbxw7a is
known to be a major regulator of cyclin E stability.26,27 Ectopic
expression of cyclin E impairs S phase progression, leading to
polyploidy and CIN.28,29 In agreement with these observations,
cell cycle analysis revealed that IEC-6 cells depleted of
Fbxw7a accumulate in S phase, with no significant change in
the proportion of G2/M phase cells (Fig. S5).
Similarly, depletion of Fbxw7b in human MCF10A cells
using validated siRNAs 27 targeting either the specific 50 exon
of b isoform or the common exon 10 of FBXW7 gene upregu-
lated Aurora A expression, while depletion of a or g isoform
had no significant effect (Fig. S6A and S6B). Silencing of
Fbxw7b in MCF10A cells also increased the proportion of cells
in G2/M and the frequency of polyploid/aneuploid cells
(Fig. S6C-F). Reciprocally, overexpression of Fbxw7b isoform,
but not Fbxw7a, in IEC-6-H-RasV12 cells was sufficient to
down-regulate Aurora A expression (Fig. 6E). These results
identify Fbxw7b isoform as a specific regulator of Aurora A.
Discussion
Aneuploidy is a hallmark of human solid tumors. Paradoxi-
cally, large-scale genomics studies have revealed that mutations
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in genes encoding mitotic regulators are very rare, arguing that
changes in the expression or activity of mitotic proteins likely
account for the high prevalence of chromosome segregation
defects observed in tumors. There is growing evidence that
oncogenic signaling pathways, which are universally dysregu-
lated in cancer, not only drive unrestrained cell proliferation
and resistance to apoptosis, but also contribute to CIN and
aneuploidy.13 However, the precise mechanisms by which
oncogenic signaling events alter the function of mitosis or cyto-
kinesis regulators remain poorly understood. We have shown
previously that hyperactivation of the ERK1/2 MAPK pathway
induces tetraploidization of intestinal epithelial cells, enhancing
their tumorigenic potential.10 Our study now provides mecha-
nistic understanding into how this oncogenic signaling path-
way impacts on the regulatory machinery of cell division. We
found that aberrant ERK1/2 signaling specifically
Figure 3. H-RasV12-induced cytokinesis failure is mediated by the ERK1/2 pathway. (A) Immunoblot analysis of proliferating IEC-6-H-RasV12 cells treated with vehicle or
1 mM PD184352 (n D 4). (B) Timing of mitotic progression of IEC-6-H-RasV12 cells treated with vehicle (n D 84) or PD184352 (n D 82). Results are expressed as mean §
SEM. (C) Quantification of cell division defects. (D) Representative cell cycle profiles of IEC-6-H-RasV12 cells treated or not with PD184352 (n D 3). (E) Proportion of cells in
each cell cycle phase (n D 3). (F) Proportion of cells with > 4N DNA content 7 d after infection of IEC-6 cells with H-RasV12 and treatment with vehicle or PD184352
(nD 3). ns, non significant; , P < 0.01; , P < 0.005.
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downregulates the F-box protein Fbxw7b, resulting in the accu-
mulation of the mitotic kinase Aurora A and cytokinesis failure.
Activating mutations in RAS genes occur in »30% of
cancers and are often acquired early in the tumorigenic
process.30,31 Several observations suggest that oncogenic Ras
signaling may contribute to cancer progression by promot-
ing genomic instability.13,14 Overexpression of oncogenic
Ras mutants in various model cell lines was shown to pro-
mote chromosome mis-segregation, centrosome amplifica-
tion, ploidy changes, and induction of CIN. Oncogenic Ras
also increases aneuploidization in mice.14,32 How Ras signal-
ing links to CIN and aneuploidy has remained largely
unclear. Early work showed that treatment with MEK1/2
inhibitor PD98059 decreases the frequency of Ras-induced
micronuclei in thyroid PCCL3 cells, pointing to the involve-
ment of the ERK1/2 signaling branch.33 We show here that
hyperactivation of ERK1/2 by H-RasV12 is both necessary
and sufficient to impair cytokinesis execution, leading to
polyploidization. Importantly, we have identified the mitotic
kinase Aurora A as a key effector of this response, provid-
ing a mechanistic link between Ras signaling and the cell
division machinery. The Aurora A kinase controls multiple
steps of the cell division cycle, including centrosome matu-
ration, mitosis entry, bipolar spindle formation, and cytoki-
nesis.16,17 Its overexpression induces cytokinesis failure and
tetraploidization 34-36; this study). Aurora A is frequently
overexpressed in human cancers as a result of gene
amplification, but also by other mechanisms such as tran-
scriptional activation and protein stabilization by upregula-
tion of interacting proteins.16,17 Our identification of the
ERK1/2 pathway as an upstream regulator of Aurora A
turnover adds an additional layer of complexity to Aurora
A regulation with potentially important implications for
cancer biology.
The destruction of Aurora A protein is controlled by multi-
ple ubiquitin ligases, including SCFbxw7.17,23-25 The SCFbxw7
ligase is a tumor suppressor protein that targets multiple onco-
proteins for ubiquitylation and degradation through its sub-
strate-binding subunit Fbxw7.37,38 The FBXW7 gene produces
3 mRNA transcripts, Fbxw7a, b and g, which consist of a spe-
cific first exon linked to 10 shared exons, allowing for isoform-
specific transcriptional control.39 Much remain to be learned
about the isoform-specific regulation and substrates of the 3
Fbxw7 isoforms. Here, we uncovered a unique mechanism of
regulation of SCFbxw7 by hyperactive ERK1/2 signaling. We
found that activated Ras or MEK markedly downregulates
Fbxw7b mRNA and protein expression in epithelial cells with-
out affecting Fbxw7a isoform. This effect is reversed by treat-
ment with the MEK1/2 inhibitor PD184352. Acute expression
of activated MEK2 in transgenic mouse intestinal cells also
decreases the levels of Fbxw7b protein. FBXW7 is mutated in
11% of non-hypermutated colorectal carcinomas.40 However,
genetic alterations in the Ras-ERK1/2 pathway are found in
55% of these tumors, suggesting that impairment of Fbxw7
Figure 4. Hyperactivation of ERK1/2 signaling downregulates Fbxw7b expression. (A) Quantitative PCR analysis of Fbxw7 isoforms mRNA levels in IEC-6 cells infected with
vector, MEK1DD or H-RasV12. Results are expressed as mean § SEM (n D 3). (B) Immunoblot analysis of Fbwx7 isoforms protein expression (n D 3). (C) Actinomycin D-
chase analysis of Fbxw7b mRNA stability in IEC-6 cells infected with vector, MEK1DD or H-RasV12. Each point corresponds to the mean § SEM of 3 individual experiments.
(D) Effect of PD184352 on mRNA levels of Fbxw7 isoforms in IEC-6-H-RasV12 cells. Mean § SEM (n D 3). (E) Effect of PD184352 on protein levels of Fbxw7b and Aurora A
in IEC-6-H-RasV12 cells (n D 3). , P < 0.005.
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Figure 5. ERK1/2 activity inversely correlates with Fbxw7b expression in MEK2DD transgenic mice. (A) Immunohistochemistry staining for phospho-ERK1/2 and Fbxw7b in
colon sections from control Villin-rtTA and Villin-rtTA;MEK2DD mice treated with doxycycline for 10 d. Right, visual quantification of phospho-ERK1/2 and Fbxw7b staining
in control (nD 4) and MEK2DD (nD 11) mice. (B) Ki-67 staining of colon sections. Right, quantification of Ki-67-positive cells per crypt. Data represent the mean§ SEM of
150 crypts, 3 mice/group. (C) Phospho-H3 staining of colon sections. Right, quantification of phospho-H3-positive cells per crypt. Mean § SEM of 150 crypts, 3 mice/
group. (D) Distribution of nuclear size of colonic epithelial cells from Villin-rtTA and Villin-rtTA;MEK2DD mice. Nuclear volume was measured on phospho-histone H3 posi-
tive crypt cells. n D 150 cells per genotype.
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function may be more prevalent than predicted by genomic
analysis.
Specific downregulation of Fbxw7b isoform by H-RasV12
signaling or RNAi silencing caused the accumulation of
Aurora A by enhancing its stability. Reciprocally, pharmaco-
logical inhibition of the ERK1/2 pathway or ectopic expression
of Fbxw7b lowered Aurora A levels. A similar inverse rela-
tionship between Fbxw7b and Aurora A was observed in
Figure 6. Fbxw7b isoform regulates Aurora A levels and the accuracy of cell division. (A) Immunoblot analysis of proliferating IEC-6 cells transfected with siRNAs targeted
to Fbxw7a or Fbxw7b isoforms (n D 4). (B) Cycloheximide-chase analysis of Aurora A stability. IEC-6 cells were either left untreated or transfected with Fbxw7b siRNA
(B2) or infected with H-RasV12. After 72 h, cycloheximide (50 mg/ml) (CHX) was added and the cells were harvested at the indicated times. Aurora A expression was moni-
tored by immunoblotting. Right, quantification of 3 experiments (mean § SEM). (C and D) Proportion of cells expressing p-H3 (C) or having >4N DNA content (D) 72 h
after transfection of IEC-6 cells with Fbxw7a or Fbxw7b siRNAs. Results are expressed as mean § SEM (n D 4). (E) Immunoblot analysis of Aurora A in proliferating IEC-6
cells infected with retrovirus-encoding Fbxw7a or Fbxw7b (n D 3).
1638 S. DUHAMEL ET AL.
human glioma cell lines.41 Concomitant to the upregulation of
Aurora A, silencing of Fbxw7b in intestinal and breast epithe-
lial cells increased the proportion of polyploid cells.
In support of our results, co-deletion of Fbxw7 and Trp53 in
the mouse intestine was reported to cause aggressive
adenocarcinomas that exhibit a CIN phenotype.42 In conclu-
sion, we propose that the ERK1/2/Fbxw7b/Aurora A axis
identified in this study may contribute to the genomic
instability and malignant progression of epithelial cancers.
Materials and methods
Reagents, plasmids and antibodies
The MEK1/2 inhibitor PD184352 was a gift from Parke-Davis.
Plasmids pBabe-HA-H-RasV12 and pBabe-HA-MEK1DD have
been described.10 pBabe-puro-Aurora A (hAur-A, plasmid
8510) 43 and pCLNR-Neo-H2B-GFP (pCLNR-H2BG, plasmid
17735) 44 retroviral constructs were purchased from Addgene.
Fbxw7a and Fbxw7b constructs were kindly provided by KI
Nakayama (Kyushu University) and subcloned into pMSCV-
hygro vector for retroviral infections.
Commercial antibodies were from the following sources:
anti-ERK1/2 from Upstate Biotechnology; anti-phospho-
ERK1/2 and anti-phospho-histone H3 from Cell Signaling
Technology; anti-HA, anti-a-tubulin, anti-Fbxw7 and anti-
GAPDH from Santa-Cruz Biotechnology; anti-Aurora A from
Invitrogen. Antibodies for immunohistochemistry: anti-phos-
pho-ERK1/2 from Cell Signaling, anti-Ki-67 from Novus Bio-
logicals and anti-Fbxw7b from LifeSpan Biosciences.
Cell culture, transfections and infections
The rat intestinal epithelial cell line IEC-6 was cultured as pre-
viously described.10 Human mammary epithelial MCF10A cells
were cultured in F12 medium supplemented with 5 ng/ml EGF,
10% fetal bovine serum, 0.5 mg/ml hydrocortisone, 10 mg/ml
insulin, 2 mM glutamine and antibiotics. Cdh1GT/GT MEFs
were obtained from S. Kuninaka (Keio University School of
Medicine) and cultured as described.45
IEC-6 and MCF10A cells were transfected with siRNAs
using Lipofectamine 2000 reagent (Invitrogen). Cells were
infected with retroviral vectors as described 46 and polyclonal
populations of infected cells were selected either for 3 d with
4 mg/ml puromycine, 5 d with 300 mg/ml hygromycin or 14 d
with 400 mg/ml G418. IEC-6 cell populations co-expressing
MEK1DD, H-RasV12 or Aurora A constructs with H2B-GFP
were obtained by simultaneous infection with pBabe-puro-
MEK1DD or pBabe-puro-H-RasV12 or pBabe-puro-Aurora A
and pCLNR-Neo-H2B-GFP, followed by selection with puro-
mycin and G418. Infection with shRNA-expressing lentiviruses
was carried out as described 47 and cells were selected with
puromycin.
RNA interference reagents
The following TRC lentiviral shRNA constructs for mouse/rat
Aurka gene were purchased from Sigma: TRCN0000025139
(shAurA-39) and TRCN0000025141 (shAurA-41).
The target sequences of the rat Fbxw7 siRNAs were:
rFbxw7a si2, 30-AUCUACUGAAACAAAGCGGdTdT-50
rFbxw7a si3, 50-CGAACUGGAGGCUCUCUGAdTdT-30
rFbxw7b si4, 50-GUUAGAAUCUGUGACAUACdTdT-30 24
rFbxw7b si6, 50-CAUAGUCUCCUCCAAUAAUdTdT-30.
The target sequences of the human FBXW7 siRNAs were:
hFbxw7 Exon 10, 50-ACAGGACAGUGUUUACAAAdTdT-30
hFbxw7a, 50-GUGAAGUUGUUGGAGUAGAdTdT-30
hFbxw7b, 50-UAUGGGUUUCUACGGCACAdTdT-30,
hFbxw7g, 50-CUACUCUAAACCAUGGCUUdTdT-30.
Immunoblotting analysis
Cell lysis and immunoblot analysis were performed as
described previously.48
Live cell imaging
IEC-6 cell populations co-expressing MEK1DD, H-RasV12 or
Aurora A with H2B-GFP were plated on 3-cm clear plates
(Greiner). After 24 h, the cells were washed twice with PBS and
cultured in 2 ml of imaging medium (Gibco) supplemented
with 5 mM Hepes (pH 7.4). All live images were acquired using
an epifluorescence microscope (personalDV, Applied Preci-
sion). The cells were imaged using a 60X/1.42 NA plan Apo
objective. For every field of cells, a stack 9 z-slice spaced
1.5 mm was collected every 3 min using a 0.15 sec exposure at
10% neutral density filtering in the fluorescence channel for
24 h, in addition to a DIC reference image. Image sequences
were viewed and annotated as overlays between maximum
intensity projections of the z-stacks with the DIC images using
SoftWoRx 3.6.2 and custom written MATLAB programs.
Cell cycle analysis
For cell cycle analysis, exponentially proliferating cells were pulsed
with 10 mM BrdU for 2 h. The cells were trypsinized, washed in
PBS, fixed in cold 70% ethanol, and kept at ¡20C until flow
cytometry analysis. For staining, the cells were washed with block-
ing buffer (0.5% bovine serum albumin in PBS), and DNA was
denatured with 2 N HCl in PBS for 20 min. The cells were washed
again and incubated for 2 min in 0.1 M sodium borate (pH 8.5) to
neutralize remaining HCl. After washing with dilution buffer
(blocking buffer with 0.5% Tween 20), the cells were incubated
with anti-BrdU antibody (2.5mg/ml) and/or anti-phospho-histone
H3 (pH3) antibody (2.5 mg/ml) for 60 min, followed by washing
with dilution buffer and incubation with Alexa Fluor 350–conju-
gated anti-mouse IgG and/or FITC-conjugated anti-rabbit IgG for
60 min. The cells were then washed with PBS and incubated on ice
for 30 min in propidium iodide (PI) buffer (0.1% sodium citrate,
50 mg/ml PI, and 0.2 mg/ml RNase) in the dark. Fluorescence was
recorded on a BD LSR II cytometer and the cell cycle distribution
or the percentage of phospho-histone H3 positive cells was ana-
lyzed using the FACSDiva software (BD Biosciences).
Real-time quantitative PCR
Total RNA was extracted from cells using the RNeasy Mini Kit
(Qiagen) and reverse transcribed using the High Capacity
cDNA Reverse Transcription Kit with random primers
CELL CYCLE 1639
(Applied Biosystems). For the rat Fbxw7 a and b isoforms,
gene expression levels were measured using custom designed
assays. For all other genes, gene expression was measured using
Universal ProbeLibrary assays (Roche). The sequences of pri-
mers and probes are available upon request. Analysis of PCR
product amplification was performed on the ABI PRISM
7900HT Sequence Detection System (Applied Biosystems). The
hypoxanthine guanine phosphoribosyl transferase (HPRT) and
GAPDH genes were used as endogenous controls for rat and
human cells. The relative level of target gene expression was
quantified by using the DDCT method.
mRNA stability assay
IEC-6 cells were treated with actinomycin D (10 mg/ml) for the
indicated times. Total RNA was extracted and the expression of
Fbxw7b mRNA was measured by quantitative PCR.
MEK2DD transgenic mice
The MEK2DD transgenic construct was generated by cloning
the human MEK2S222D/S226D (MEK2DD) mutant cDNA
downstream of a heptameric TetO element fused to a minimal
CMV promoter (Fig. S4a). The construct was injected into fer-
tilized eggs and 6 transgenic founders were identified by South-
ern blotting and further analyzed for inducibility and
repressibility of the transgene. MEK2DD founder lines were
bred to Villin-rtTA transgenic mice, which express the reverse
tetracycline-regulated transactivator (rtTA) specifically in the
gastrointestinal epithelium.49 Bitransgenic Villin-rtTA;MEK2D
D mice were found to express MEK2DD exclusively upon
doxycycline induction in a dose-dependent manner (Fig. S4b).
As expected, MEK2DD expression led to a marked increased in
the activating phosphorylation of ERK1/2 (Fig. 5a). To evaluate
the impact of MEK2 hyperactivation in the intestine, bitrans-
genic Villin-rtTA;MEK2DD and littermate monotransgenic
Villin-rtTA control mice were fed with 500 mg/ml doxycycline
at 6 weeks of age for the indicated times. All mice were housed
under specific-pathogen free conditions, and experiments were
performed in accordance with the Canadian Council on Ani-
mal Care guidelines and with Universite de Montreal Institu-
tional Animal Care and Use Committee approval.
Immunohistochemistry
The colons from transgenic mice were dissected, fixed in 10%
formalin, embedded in paraffin, and processed for histopatho-
logical analysis. For immunohistochemical staining, colon
specimens were deparaffinized in an automated immunostainer
(Discovery XT, Ventana Medical Systems). Heat-induced epi-
tope retrieval (HIER) and blocking steps were performed using
proprietary reagents (Cell Conditionner 1 and 2, Inhibitor D
and Blocker D included in DABmap detection kit (Ventana
Medical Systems)). Sections were then incubated with anti-
phospho-ERK1/2 (Cell Signaling Technology; 1:100), anti-
Fbxw7b (LifeSpan Biosciences; 1:100), or anti-phospho-histone
H3 (Cell Signaling Technology; 1:50) antibody for 1 h at room
temperature. Bound antibody was detected with biotin-conju-
gated anti-rabbit IgG secondary antibody at 1:100 dilution
(Jackson ImmunoResearch Laboratories). Nuclei were counter-
stained with haematoxylin. For measurement of nucleus vol-
ume, colon sections were stained with anti-phospho-histone
H3 antibody to label cells in G2/M phase. Microscopic fields
were randomly selected and the diameter of the nucleus was
measured along the major and minor axes. The mean value of
the 2 diameters was used to calculate the nucleus volume using
the equation v D (4/3) p r3. A total of 150 phospho-histone H3
positive cells were scored for each genotype. To assess the cor-
relation of phospho-ERK1/2 and Fbxw7b staining, colon sec-
tions were scored blinded by 2 readers.
Statistical analysis
Results are expressed as the mean § SEM. Unpaired t test was
performed unless otherwise indicated (Excel).
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